MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $64 | -99.9% | 239 | 0.0% | 0.00% | – |
| Q3 2022 | $88,000 | +11.4% | 239 | 0.0% | 0.00% | – |
| Q2 2022 | $79,000 | -41.5% | 239 | -21.9% | 0.00% | – |
| Q1 2022 | $135,000 | -40.5% | 306 | +28.0% | 0.00% | – |
| Q4 2021 | $227,000 | -59.0% | 239 | -26.9% | 0.00% | – |
| Q3 2021 | $553,000 | -57.3% | 327 | -29.5% | 0.00% | – |
| Q2 2021 | $1,295,000 | -89.6% | 464 | -91.6% | 0.00% | – |
| Q1 2021 | $12,410,000 | +67.8% | 5,540 | +8.6% | 0.00% | – |
| Q4 2020 | $7,395,000 | -34.8% | 5,100 | -32.6% | 0.00% | – |
| Q3 2020 | $11,349,000 | +126.1% | 7,566 | +212.0% | 0.00% | – |
| Q2 2020 | $5,020,000 | -68.4% | 2,425 | -71.0% | 0.00% | – |
| Q1 2020 | $15,884,000 | +45.4% | 8,360 | +120.5% | 0.00% | – |
| Q4 2019 | $10,921,000 | -37.9% | 3,792 | +10.1% | 0.00% | – |
| Q3 2019 | $17,599,000 | +3076.7% | 3,444 | +4820.0% | 0.00% | – |
| Q2 2019 | $554,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |